ConvaTec welcomes new GM
With over two decades of senior leadership expertise in the healthcare industry, Karen O’Connor has been appointed as the new General Manager for ConvaTec in Australia and New Zealand.
Highly experienced with strong strategic and management skills, O’Connor has had a prominent and successful career with leading global healthcare companies including Boston Scientific, Physio-Control (now Stryker) and Johnson & Johnson.
“I’m delighted to be joining ConvaTec and looking forward to working with the teams both in Australia and New Zealand to ensure ConvaTec remains an innovative and leading player in stoma care, wound therapeutics, continence and critical care,” explained O’Connor.
“These are exciting times for ConvaTec as we’re going against the grain and investing heavily in people and projects to deliver even better results for the patients they touch.
“I’m passionate about inspiring and empowering both individuals and teams to embrace and exceed their goals and am looking forward to doing this at ConvaTec.”
O’Connor is moving to ConvaTec from Boston Scientific, where, over two years, she grew the Endoscopy Business Unit. Prior to that she was Country Manager, ANZ, for Physio-Control (Stryker), a leader in the development, manufacture and sale of defibrillators, monitors and emergency medical response products. She began and grew her career with Johnson & Johnson across a number of franchises before becoming the National Sales Director for the Advanced Sterilization Products, Infection Control and Wound Care business.
In addition to health care, O’Connor has worked in strategic leadership with Deloitte and holds a Masters of Business Administration and Masters of Management.
“With her exceptional skills and expertise, I’m very pleased to welcome Karen to ConvaTec and am confident she’ll take the business to new heights,” said Supratim Bose, President of ConvaTec (Asia Pacific).
Bankstown-Lidcombe and Liverpool Hospitals trial body cameras
Bankstown-Lidcombe and Liverpool Hospitals have joined three other participating hospitals in the...
Western Sydney Local Health District prosecution withdrawn
A "landmark psychosocial risk prosecution" against Western Sydney Local Health District...
Queensland extends $6m community pharmacist training subsidy
The Queensland Government has extended its training subsidy so up to 230 additional pharmacists...